|$61.230||BULLISH on US MARKET||US EQUITIES||No|
(Market Call Minute.) Splitting in two. Their pharma business is going to be priced more cheaply but be careful because their major drug is 47% of this. To concentrated. He would look at the other piece when they split.
President and CEO, GoodReid Investment Counsel